I last saw my rheumatologist nearly 18 months ago and it was only after I had my appointment that I realised I hadn't been given a date for my next appointment, as was usually the case. I assumed that this was due to the backlog caused by Covid and thought nothing more about it until last autumn. But then my husband was very unwell and I didn't get round to doing anything until recently.
I have now been told by the rheumatology secretary that I have been put onto something called the Patient Initiated Returns List by my rheumatologist. This apparently runs for 2 years at a time and, as the name suggests, enables the patient to make an appointment if they deem one necessary. At the 2 year point the rheumatologist then decides whether the patient should stay on the list, go onto a higher priority list, or be discharged (apparently the patient isn't told if the latter! Presumably they find out via their GP??).
My rheumy should have told me this, but didn't - presumably this was overlooked in the chaos of Covid and its effects across the health service. Anyhow, I am wondering how being on the PIRL will affect me and would welcome experiences from others in a similar position. I am in Scotland (I don't know if such lists operate elsewhere in the UK), have Antiphospholipid Syndrome, Lupus, and a host of other conditions, and am on ESA. I am particularly concerned that being on the PIRL or even not being under a consultant (were I to be discharged - the rheumy has been a key player in so many aspects of my care up to now) would make my re-assessments for ESA so much harder. I am also concerned about having to make judgements myself as to whether to request an appointment, and having to rely more on my GP to manage my APS in particular - a condition about which they have little knowledge, certainly not beyond the major risks.
My gut feeling is that I must request an appointment before the current 2 years period under which I am on the PIRL ends, even if I feel all is ticking along okay - simply to get to speak to the rheumy about this and how my future care will pan out. I can only assume that there will be many other patients in a similar position to me, not just under the care of rheumatology but across NHS disciplines. It would be good to hear from others here. And is this a way to manage growing demand and declining medic numbers? It certainly has me rather worried